Trial · NCT02134314
Adverse events76
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 76
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Diabetic Ketoacidosis | Endocrine disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 1 | 35 | 1 |
| serious | Diabetic Ketoacidosis | Endocrine disorders | Normal Saline | 0 | 35 | 0 |
| serious | Flash pulmonary edema | Respiratory, thoracic and mediastinal disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 1 | 35 | 1 |
| serious | Flash pulmonary edema | Respiratory, thoracic and mediastinal disorders | Normal Saline | 0 | 35 | 0 |
| serious | Dyspnea on exertion | Respiratory, thoracic and mediastinal disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 1 | 35 | 1 |
| serious | Dyspnea on exertion | Respiratory, thoracic and mediastinal disorders | Normal Saline | 0 | 35 | 0 |
| serious | A fib, shortness of breath, chest pain | Cardiac disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 1 | 35 | 1 |
| serious | A fib, shortness of breath, chest pain | Cardiac disorders | Normal Saline | 0 | 35 | 0 |
| serious | Right leg DVT | Cardiac disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 0 | 35 | 0 |
| serious | Right leg DVT | Cardiac disorders | Normal Saline | 1 | 35 | 1 |
| serious | Upper extermity/facial swelling, SVC syndrome | Cardiac disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 0 | 35 | 0 |
| serious | Upper extermity/facial swelling, SVC syndrome | Cardiac disorders | Normal Saline | 1 | 35 | 1 |
| serious | A flutter | Cardiac disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 0 | 35 | 0 |
| serious | A flutter | Cardiac disorders | Normal Saline | 1 | 35 | 1 |
| serious | Afib/ventricular tachycardia | Cardiac disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 0 | 35 | 0 |
| serious | Afib/ventricular tachycardia | Cardiac disorders | Normal Saline | 1 | 35 | 1 |
| serious | Hypertension | Cardiac disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 0 | 35 | 0 |
| serious | Hypertension | Cardiac disorders | Normal Saline | 1 | 35 | 1 |
| serious | Non ST segment elevation | Cardiac disorders | C1-Inhibitor (Berinert) (Human) (C1INH) | 1 | 35 | 1 |
| serious | Non ST segment elevation | Cardiac disorders | Normal Saline | 0 | 35 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02134314/events?page=3